The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Urinary Follicle Stimulating Hormone Market Research Report 2025
Synopsis
FSH levels are higher in women who are menopausal making their urine a good source for extraction. Pergonal also contains leutinizing hormone (LH) which produces many effects including higher estrogen levels. So, FSH can be extracted from urine.
The global Urinary Follicle Stimulating Hormone market was valued at US$ 229.5 million in 2023 and is anticipated to reach US$ 334.3 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
North American market for Urinary Follicle Stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Urinary Follicle Stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Urinary Follicle Stimulating Hormone include IBSA, Ferring and Livzon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Urinary Follicle Stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Follicle Stimulating Hormone.
Report Scope
The Urinary Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urinary Follicle Stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urinary Follicle Stimulating Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IBSA
Ferring
Livzon
Segment by Type
75IU
150IU
Others
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urinary Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Urinary Follicle Stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
FSH levels are higher in women who are menopausal making their urine a good source for extraction. Pergonal also contains leutinizing hormone (LH) which produces many effects including higher estrogen levels. So, FSH can be extracted from urine.
The global Urinary Follicle Stimulating Hormone market was valued at US$ 229.5 million in 2023 and is anticipated to reach US$ 334.3 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
North American market for Urinary Follicle Stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Urinary Follicle Stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Urinary Follicle Stimulating Hormone include IBSA, Ferring and Livzon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Urinary Follicle Stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Follicle Stimulating Hormone.
Report Scope
The Urinary Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urinary Follicle Stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urinary Follicle Stimulating Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IBSA
Ferring
Livzon
Segment by Type
75IU
150IU
Others
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urinary Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Urinary Follicle Stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Urinary Follicle Stimulating Hormone Market Overview
1.1 Product Overview and Scope of Urinary Follicle Stimulating Hormone
1.2 Urinary Follicle Stimulating Hormone Segment by Type
1.2.1 Global Urinary Follicle Stimulating Hormone Market Value Comparison by Type (2024-2030)
1.2.2 75IU
1.2.3 150IU
1.2.4 Others
1.3 Urinary Follicle Stimulating Hormone Segment by Application
1.3.1 Global Urinary Follicle Stimulating Hormone Market Value by Application: (2024-2030)
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Global Urinary Follicle Stimulating Hormone Market Size Estimates and Forecasts
1.4.1 Global Urinary Follicle Stimulating Hormone Revenue 2019-2030
1.4.2 Global Urinary Follicle Stimulating Hormone Sales 2019-2030
1.4.3 Global Urinary Follicle Stimulating Hormone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Urinary Follicle Stimulating Hormone Market Competition by Manufacturers
2.1 Global Urinary Follicle Stimulating Hormone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Urinary Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Urinary Follicle Stimulating Hormone Average Price by Manufacturers (2019-2024)
2.4 Global Urinary Follicle Stimulating Hormone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Product Type & Application
2.7 Urinary Follicle Stimulating Hormone Market Competitive Situation and Trends
2.7.1 Urinary Follicle Stimulating Hormone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Urinary Follicle Stimulating Hormone Players Market Share by Revenue
2.7.3 Global Urinary Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Urinary Follicle Stimulating Hormone Retrospective Market Scenario by Region
3.1 Global Urinary Follicle Stimulating Hormone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Urinary Follicle Stimulating Hormone Global Urinary Follicle Stimulating Hormone Sales by Region: 2019-2030
3.2.1 Global Urinary Follicle Stimulating Hormone Sales by Region: 2019-2024
3.2.2 Global Urinary Follicle Stimulating Hormone Sales by Region: 2025-2030
3.3 Global Urinary Follicle Stimulating Hormone Global Urinary Follicle Stimulating Hormone Revenue by Region: 2019-2030
3.3.1 Global Urinary Follicle Stimulating Hormone Revenue by Region: 2019-2024
3.3.2 Global Urinary Follicle Stimulating Hormone Revenue by Region: 2025-2030
3.4 North America Urinary Follicle Stimulating Hormone Market Facts & Figures by Country
3.4.1 North America Urinary Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Urinary Follicle Stimulating Hormone Sales by Country (2019-2030)
3.4.3 North America Urinary Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Urinary Follicle Stimulating Hormone Market Facts & Figures by Country
3.5.1 Europe Urinary Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Urinary Follicle Stimulating Hormone Sales by Country (2019-2030)
3.5.3 Europe Urinary Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Urinary Follicle Stimulating Hormone Market Facts & Figures by Country
3.6.1 Asia Pacific Urinary Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Urinary Follicle Stimulating Hormone Sales by Country (2019-2030)
3.6.3 Asia Pacific Urinary Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Urinary Follicle Stimulating Hormone Market Facts & Figures by Country
3.7.1 Latin America Urinary Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Urinary Follicle Stimulating Hormone Sales by Country (2019-2030)
3.7.3 Latin America Urinary Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Urinary Follicle Stimulating Hormone Market Facts & Figures by Country
3.8.1 Middle East and Africa Urinary Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Urinary Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Urinary Follicle Stimulating Hormone Sales by Type (2019-2030)
4.1.1 Global Urinary Follicle Stimulating Hormone Sales by Type (2019-2024)
4.1.2 Global Urinary Follicle Stimulating Hormone Sales by Type (2025-2030)
4.1.3 Global Urinary Follicle Stimulating Hormone Sales Market Share by Type (2019-2030)
4.2 Global Urinary Follicle Stimulating Hormone Revenue by Type (2019-2030)
4.2.1 Global Urinary Follicle Stimulating Hormone Revenue by Type (2019-2024)
4.2.2 Global Urinary Follicle Stimulating Hormone Revenue by Type (2025-2030)
4.2.3 Global Urinary Follicle Stimulating Hormone Revenue Market Share by Type (2019-2030)
4.3 Global Urinary Follicle Stimulating Hormone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Urinary Follicle Stimulating Hormone Sales by Application (2019-2030)
5.1.1 Global Urinary Follicle Stimulating Hormone Sales by Application (2019-2024)
5.1.2 Global Urinary Follicle Stimulating Hormone Sales by Application (2025-2030)
5.1.3 Global Urinary Follicle Stimulating Hormone Sales Market Share by Application (2019-2030)
5.2 Global Urinary Follicle Stimulating Hormone Revenue by Application (2019-2030)
5.2.1 Global Urinary Follicle Stimulating Hormone Revenue by Application (2019-2024)
5.2.2 Global Urinary Follicle Stimulating Hormone Revenue by Application (2025-2030)
5.2.3 Global Urinary Follicle Stimulating Hormone Revenue Market Share by Application (2019-2030)
5.3 Global Urinary Follicle Stimulating Hormone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 IBSA
6.1.1 IBSA Corporation Information
6.1.2 IBSA Description and Business Overview
6.1.3 IBSA Urinary Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 IBSA Urinary Follicle Stimulating Hormone Product Portfolio
6.1.5 IBSA Recent Developments/Updates
6.2 Ferring
6.2.1 Ferring Corporation Information
6.2.2 Ferring Description and Business Overview
6.2.3 Ferring Urinary Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ferring Urinary Follicle Stimulating Hormone Product Portfolio
6.2.5 Ferring Recent Developments/Updates
6.3 Livzon
6.3.1 Livzon Corporation Information
6.3.2 Livzon Description and Business Overview
6.3.3 Livzon Urinary Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Livzon Urinary Follicle Stimulating Hormone Product Portfolio
6.3.5 Livzon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Urinary Follicle Stimulating Hormone Industry Chain Analysis
7.2 Urinary Follicle Stimulating Hormone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Urinary Follicle Stimulating Hormone Production Mode & Process
7.4 Urinary Follicle Stimulating Hormone Sales and Marketing
7.4.1 Urinary Follicle Stimulating Hormone Sales Channels
7.4.2 Urinary Follicle Stimulating Hormone Distributors
7.5 Urinary Follicle Stimulating Hormone Customers
8 Urinary Follicle Stimulating Hormone Market Dynamics
8.1 Urinary Follicle Stimulating Hormone Industry Trends
8.2 Urinary Follicle Stimulating Hormone Market Drivers
8.3 Urinary Follicle Stimulating Hormone Market Challenges
8.4 Urinary Follicle Stimulating Hormone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Urinary Follicle Stimulating Hormone Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Urinary Follicle Stimulating Hormone Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Urinary Follicle Stimulating Hormone Market Competitive Situation by Manufacturers in 2023
Table 4. Global Urinary Follicle Stimulating Hormone Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Urinary Follicle Stimulating Hormone Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Urinary Follicle Stimulating Hormone Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Urinary Follicle Stimulating Hormone Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Urinary Follicle Stimulating Hormone, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Product Type & Application
Table 12. Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Urinary Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Follicle Stimulating Hormone as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Urinary Follicle Stimulating Hormone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Urinary Follicle Stimulating Hormone Sales by Region (2019-2024) & (K Doses)
Table 18. Global Urinary Follicle Stimulating Hormone Sales Market Share by Region (2019-2024)
Table 19. Global Urinary Follicle Stimulating Hormone Sales by Region (2025-2030) & (K Doses)
Table 20. Global Urinary Follicle Stimulating Hormone Sales Market Share by Region (2025-2030)
Table 21. Global Urinary Follicle Stimulating Hormone Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Region (2019-2024)
Table 23. Global Urinary Follicle Stimulating Hormone Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Region (2025-2030)
Table 25. North America Urinary Follicle Stimulating Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Urinary Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 27. North America Urinary Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 28. North America Urinary Follicle Stimulating Hormone Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Urinary Follicle Stimulating Hormone Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Urinary Follicle Stimulating Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Urinary Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Urinary Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Urinary Follicle Stimulating Hormone Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Urinary Follicle Stimulating Hormone Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Urinary Follicle Stimulating Hormone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Urinary Follicle Stimulating Hormone Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Urinary Follicle Stimulating Hormone Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Urinary Follicle Stimulating Hormone Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Urinary Follicle Stimulating Hormone Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Urinary Follicle Stimulating Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Urinary Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Urinary Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Urinary Follicle Stimulating Hormone Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Urinary Follicle Stimulating Hormone Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Urinary Follicle Stimulating Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Urinary Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Urinary Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Urinary Follicle Stimulating Hormone Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Urinary Follicle Stimulating Hormone Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Urinary Follicle Stimulating Hormone Sales (K Doses) by Type (2019-2024)
Table 51. Global Urinary Follicle Stimulating Hormone Sales (K Doses) by Type (2025-2030)
Table 52. Global Urinary Follicle Stimulating Hormone Sales Market Share by Type (2019-2024)
Table 53. Global Urinary Follicle Stimulating Hormone Sales Market Share by Type (2025-2030)
Table 54. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Type (2019-2024)
Table 57. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Type (2025-2030)
Table 58. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Type (2019-2024)
Table 59. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Type (2025-2030)
Table 60. Global Urinary Follicle Stimulating Hormone Sales (K Doses) by Application (2019-2024)
Table 61. Global Urinary Follicle Stimulating Hormone Sales (K Doses) by Application (2025-2030)
Table 62. Global Urinary Follicle Stimulating Hormone Sales Market Share by Application (2019-2024)
Table 63. Global Urinary Follicle Stimulating Hormone Sales Market Share by Application (2025-2030)
Table 64. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Application (2019-2024)
Table 67. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Application (2025-2030)
Table 68. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Application (2019-2024)
Table 69. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Application (2025-2030)
Table 70. IBSA Corporation Information
Table 71. IBSA Description and Business Overview
Table 72. IBSA Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. IBSA Urinary Follicle Stimulating Hormone Product
Table 74. IBSA Recent Developments/Updates
Table 75. Ferring Corporation Information
Table 76. Ferring Description and Business Overview
Table 77. Ferring Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Ferring Urinary Follicle Stimulating Hormone Product
Table 79. Ferring Recent Developments/Updates
Table 80. Livzon Corporation Information
Table 81. Livzon Description and Business Overview
Table 82. Livzon Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Livzon Urinary Follicle Stimulating Hormone Product
Table 84. Livzon Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Urinary Follicle Stimulating Hormone Distributors List
Table 88. Urinary Follicle Stimulating Hormone Customers List
Table 89. Urinary Follicle Stimulating Hormone Market Trends
Table 90. Urinary Follicle Stimulating Hormone Market Drivers
Table 91. Urinary Follicle Stimulating Hormone Market Challenges
Table 92. Urinary Follicle Stimulating Hormone Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Urinary Follicle Stimulating Hormone
Figure 2. Global Urinary Follicle Stimulating Hormone Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Urinary Follicle Stimulating Hormone Market Share by Type in 2023 & 2030
Figure 4. 75IU Product Picture
Figure 5. 150IU Product Picture
Figure 6. Others Product Picture
Figure 7. Global Urinary Follicle Stimulating Hormone Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Urinary Follicle Stimulating Hormone Market Share by Application in 2023 & 2030
Figure 9. Infertility Treatment
Figure 10. Assisted Reproductive Technology
Figure 11. Global Urinary Follicle Stimulating Hormone Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Urinary Follicle Stimulating Hormone Market Size (2019-2030) & (US$ Million)
Figure 13. Global Urinary Follicle Stimulating Hormone Sales (2019-2030) & (K Doses)
Figure 14. Global Urinary Follicle Stimulating Hormone Average Price (USD/Dose) & (2019-2030)
Figure 15. Urinary Follicle Stimulating Hormone Report Years Considered
Figure 16. Urinary Follicle Stimulating Hormone Sales Share by Manufacturers in 2023
Figure 17. Global Urinary Follicle Stimulating Hormone Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Urinary Follicle Stimulating Hormone Players: Market Share by Revenue in 2023
Figure 19. Urinary Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Urinary Follicle Stimulating Hormone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Urinary Follicle Stimulating Hormone Sales Market Share by Country (2019-2030)
Figure 22. North America Urinary Follicle Stimulating Hormone Revenue Market Share by Country (2019-2030)
Figure 23. United States Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Urinary Follicle Stimulating Hormone Sales Market Share by Country (2019-2030)
Figure 26. Europe Urinary Follicle Stimulating Hormone Revenue Market Share by Country (2019-2030)
Figure 27. Germany Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Urinary Follicle Stimulating Hormone Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Urinary Follicle Stimulating Hormone Revenue Market Share by Region (2019-2030)
Figure 34. China Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Urinary Follicle Stimulating Hormone Sales Market Share by Country (2019-2030)
Figure 44. Latin America Urinary Follicle Stimulating Hormone Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Urinary Follicle Stimulating Hormone Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Urinary Follicle Stimulating Hormone Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Urinary Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Urinary Follicle Stimulating Hormone by Type (2019-2030)
Figure 54. Global Revenue Market Share of Urinary Follicle Stimulating Hormone by Type (2019-2030)
Figure 55. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Type (2019-2030)
Figure 56. Global Sales Market Share of Urinary Follicle Stimulating Hormone by Application (2019-2030)
Figure 57. Global Revenue Market Share of Urinary Follicle Stimulating Hormone by Application (2019-2030)
Figure 58. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Application (2019-2030)
Figure 59. Urinary Follicle Stimulating Hormone Value Chain
Figure 60. Urinary Follicle Stimulating Hormone Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
